McKesson, CD&R Near $5 Billion-Plus Deal to Buy Option Care, FT Reports

Drug distributor McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services provider Option Care Health in a transaction valued at more than $5 billion, including debt, the Financial Times reported on Monday, citing people familiar with the matter.

Option Care's shares rose 21% in extended trading following the report.

The deal could be announced as soon as Tuesday, although talks could still fall apart, the report said.

The possible acquisition would mark McKesson's latest deal as it seeks to expand its healthcare services footprint. In August, the company agreed to buy Precision Medicine Group for about $2.25 billion as part of a years-long effort to strengthen its higher-growth businesses. Reuters reports.

🧪 60 Degrees Pharmaceuticals Stock Falls 6% in Pre-Market Ahead of Tafenoquine Trial Interim Results

The company shares fell about 6.22% to $1.35 in the pre-market session on Tuesday ahead of interim results from a trial of tafenoquine in patients hospitalized with severe babesiosis.

On Monday, the Washington-based pharmaceutical company’s stock closed at $1.44, up 3.60%.

The stock move came ahead of the company’s planned disclosure of interim results from its clinical study of tafenoquine in patients hospitalized with severe babesiosis.

Babesiosis is a tick-borne disease caused by parasites that infect red blood cells. According to the company, no FDA-approved treatment or vaccine exists for the disease. Tafenoquine is not approved by the FDA to treat or prevent the infection. Benzinga reports.

🔋 E-Power (EPOW) Stock Soars Over 11% After-Hours: What's Driving the Surge?

E-Power Inc. (NASDAQ: EPOW) shares rose 11.14% to $4.19 in after-hours trading on Monday.

The China-based company, which primarily manufactures and sells graphite anode materials for lithium-ion batteries, closed the regular session at $3.77, down 12.12%.

Last week, E-Power announced a securities purchase agreement with a non-U.S. investor for approximately $1.87 million in a registered direct offering.

The company agreed to sell 229,097 Class A ordinary shares at $3.60 each. It also agreed to sell pre-funded warrants for up to 292,393 shares at $3.59 each. The warrants are immediately exercisable at $0.01 per share.

E-Power said it will use the net proceeds for working capital and general corporate purposes.

Florida-based investment bank FT Global Capital, Inc. is serving as the exclusive placement agent. Benzinga reports.

🖥️ Why Citi Now Thinks AMD Stock Could Rip Another 25% Because of Meta Muse

AMD shares have more record highs in their future, according to Citi.

Citi analyst Atif Malik raised his price target on AMD to $800 from $575 on Tuesday. Shares rose 1% in pre-market trading and look set to open at another record high.

"Following the release of Meta (META) Muse and our subsequent CPU TAM raise, we are raising estimates on AMD given our belief that AMD will be the primary beneficiary of the CPU renaissance and our belief that Meta is one of the largest customers of AMD's server business," Malik said.

Malik also struck a more bullish tone on the future size of the CPU market. Yahoo Finance reports.

🧠 AMD CEO Sees Very High Chip Demand, Urges AI Firms to Cooperate

Advanced Micro Devices Inc. CEO Lisa Su predicted "very high" chip demand will continue for the next few years, even as the industry faces challenges such as concerns over AI safety.

Even with increases in AMD's output, demand is outpacing supply, the chief executive officer told reporters in Taipei on Tuesday. She also urged leading artificial intelligence companies to cooperate on ensuring the technology causes no harm.

Su's optimism reinforces bullish views across the AI industry, including a robust outlook from U.S. memory chipmaker Micron Technology Inc. and better-than-expected quarterly sales from server assembler Hon Hai Precision Industry Co. Still, some investors are growing increasingly concerned about industry overcapacity, rising debt levels, and regulatory setbacks. Yahoo Finance reports.

🧩 More Than 40% of S&P 500 Stocks Are in Bear-Market

The S&P 500 was trading within 2 percentage points of its record closing high on Tuesday, but performance beneath the index level was more mixed.

While strong performance from a minority of high-flying artificial intelligence stocks has helped support the index, an analysis found that more than 40% of stocks in the S&P 500 were trading at least 20% below their 52-week highs as of Monday’s close.

That means a significant share of the index’s constituents were trading in bear-market territory based on the commonly used 20% threshold, highlighting a widening gap between the market’s stronger and weaker performers. MarketWatch reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.

1) AIXI: Xiao-I Corporation
Total gain: +146.03%

2) JAGX: Jaguar Health, Inc.
Total gain: +33.40%

3) CTSO: Cytosorbents Corporation
Total gain: +28.63%

4) APOG: Apogee Enterprises, Inc.
Total gain: +20.56%

5) OPCH: Option Care Health, Inc.
Total gain: +19.98%

The closing price of the top three market percent gainers trading near or above $2 on Oct 5.

(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET). Stock Analysis reports.

1) SAIQ: WISeSat.Space Holdings Corp.
Total gain: +260.54%

The stock appeared to be moving on no notable news.

2) PSKY: Paramount Skydance Corporation
Total gain: +105.79%

The company announced their CEO Leadership Team (CLT) expected to lead the combined company, to be named Skydance, following the anticipated close of Paramount's acquisition of Warner Bros. Discovery, Inc. Drawing on deep expertise across entertainment, technology, and business operations, the CLT brings together leaders from both companies and reflects their complementary strengths. Each will report directly to the CEOs. PRNewswire reports.

3) VEEA: Veea Inc.
Total gain: +71.77%

The stock appeared to be moving on no notable news.

(Estimate and Actual numbers represent Earnings Per Share in US Dollars)

RPM

RPM International

Q1 2027

Before Market Open

Estimate: 1.950

Actual: 1.980

APOG

Apogee Enterprises

Q2 2027

Before Market Open

Estimate: 0.630

Actual: 1.170

STZ

Constellation Brands

Q2 2027

After Market Close

Estimate: 3.560

Actual: N/A

Time (ET) / Report / Period

• 8:30 AM / U.S. Trade Balance / Aug.
• 6:00 PM / FRB Dallas President Lorie Logan participates in Global Perspectives event

“The investor's chief problem, and even his worst enemy, is likely to be himself.”

– Benjamin Graham

Sourced in: The Intelligent Investor

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.

The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.

Investing involves risk, including the possible loss of principal.

There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.

Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.

Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.

Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.

Copyright © TradeZero 2026. All rights reserved.